La santé – Facteur essentiel de développement

L'action de la DDC dans le domaine de la santé

© ddc

L’action de la DDC dans le domaine de la santé porte sur trois thèmes: le renforcement des systèmes de santé, la lutte contre les maladies transmissibles et non transmissibles et l’amélioration de la santé sexuelle, reproductive, maternelle, néonatale et infantile. La DDC intervient dans des pays à faible et moyen revenus, dans des contextes stables ou fragiles, ainsi que dans des économies en transition.

Renforcement des systèmes de santé

Assurer la qualité des infrastructures, des équipements, des médicaments et des technologies médicales; promouvoir l’accès aux soins, le financement de la santé, la gouvernance et la gestion du secteur; assurer la formation et le suivi des professionnels de santé.

Santé sexuelle et reproductive

Améliorer la santé des mères, des nouveaux nés et des enfants; promouvoir la santé sexuelle et reproductive ainsi que les droits de l’homme relatifs à ces domaines.

Maladies

Mise en place de stratégies de promotion de la santé, de prévention et de diagnostic et traitement des maladies non transmissibles; soutenir la prévention, le traitement, la recherche de nouveaux médicaments et d’outils diagnostics contre les maladies tropicales négligées, le paludisme, la tuberculose, le sida, les diarrhées et les infections respiratoires aiguës.

Documents

Projets actuels

Objet 13 – 24 de 134

Governing Health Futures 2030 Youth Network

01.10.2020 - 30.06.2023

Stronger governance of digital technology, data and artificial intelligence is required to maximise the benefits – and mitigate the risks – of health in a digital age for the next generation. To date, young people’s needs and perspectives have been largely overlooked in the design, application and governance of digital health and data. Through this proposal, Switzerland will support greater youth involvement in governing health futures.


COVID-19 Therapeutics Accelerator

01.10.2020 - 30.09.2023

The COVID-19 pandemic affects people worldwide, also in low and middle-income countries where health systems are even less prepared to respond to health shocks. In order to save lives, reduce the need for hospitalization and hence to relieve health systems, safe and efficacious preventive and curative treatments are needed. Switzerland supports research and development of and access to COVID-19 treatments – an area where Swiss science and pharma are strongly engaged.


The Global Vaccine Alliance Gavi

01.10.2020 - 31.12.2025

People in low and lower- middle-income countries are particularly vulnerable to the COVID-19 pandemic as they often rely on fragile health systems to fight it. Because of the pandemic, routine immunization campaigns have been stopped or massively scaled-down, which in turn will severely impact the health of millions in these countries. Switzerland supports the Geneva-based Vaccine Alliance Gavi to provide equitable access to vaccines, including a future COVID-19 vaccine.


Open source Health Insurance Management Information System (openHIMIS)

01.09.2020 - 31.12.2023

Many middle- and low-income countries strive to set up or expand national, district- or community- based health insurance schemes. For effective business processes bigger schemes require appropriate health insurance information management systems. Yet, countries have insufficient capacities to set up and manage such systems. The initiative aims to develop an open source, hence affordable and cost-effective ICT-based system with no restrictions on its use, change or distribution.


Open source Health Insurance Management Information System (OpenIMIS)

01.09.2020 - 31.08.2023

Health related costs often represent a massive financial burden for poor households. Lack or inexistence of social protection mechanisms imply that ill and injured people have no choice but to pay out-of-pocket for services and care. Health insurance schemes potentially prevent households from falling into a poverty trap. SDC and BMZ have developed the only open-source software for fully managing a social health protection scheme. This tool will be further promoted and implemented in LMICs.


Access to COVID-19 Diagnostics

01.09.2020 - 31.08.2023

Testing the right people, at the right moment and with the right tool is essential for the Covid-19 pandemic management. Both the Swiss international cooperation and the Swiss pharmaceutical sector have a long-standing experience and interest in supporting R&D, access and manufacturing of diagnostics.. The Foundation for Innovative New Diagnostics (FIND) is leading the global effort (ACT-A Dx Partnership) in the development of affordable COVID-19 diagnostics and local manufacturing capacity for and in LMICs.  


Fighting COVID-19 and strengthening the health infrastructure with sustainable energy

01.09.2020 - 30.06.2022

The electrification of healthcare facilities is an important enabler of the quality and functioning of essential health services, including for the diagnosis and management of COVID-19 patients. At the same time, survival of the mini-grid and offgrid industry is key for providing everyone with sustainable energy access. In response to the COVID-19 pandemic, Switzerland supports a joint initiative by the World Bank, Gavi and the World Health Organisation to accelerate electrification of health care facilities and provide liquidity to financially suffering mini-grid and offgrid companies.


WHO R&D Blueprint COVID-19

01.09.2020 - 31.08.2023

At present, there are no vaccines, no curative treatments and a strong need for more rapid diagnostic tests for COVID-19. Therefore, research is needed to accelerate timely, adequate, affordable and equitable access to these products. Switzerland supports WHO efforts to elaborate a research roadmap based on knowledge gaps for COVID-19 pandemic treatments, vaccines and related epidemiological studies, with a focus on low- and middle income countries.


Health Facilities Autonomy

01.08.2020 - 31.07.2023

Strong management and leadership’s capacity of decision-makers and health managers is central for a successful health reform. The project strengthens the health management system by modernizing continuous skills development and by updating regulations towards a transparent and competency based appointment as well as performance assessment of health managers.

 

 


Innovative Vector Control Consortium (IVCC)

01.08.2020 - 31.07.2024

Vector-borne neglected tropical diseases (NTDs) and malaria are major causes of mortality, morbidity and lack of economic progress for the poorest. Targeting the vector (mosquito) is a main eradication approach. Due to climate change and natural mutation, insecticide resistance is affecting most malaria endemic countries. The Innovative Vector Control Consortium (IVCC) is the world-leader Product Development Partnership developing innovative and safe insecticides. SDC strategic support to IVCC complements Switzerland’s global action against malaria. 


WFP/UNHAS common services for Southeast Asia during COVID-19

12.06.2020 - 31.12.2020

Contribution by two funding entities (Humanitarian Aid and South Cooperation) to support WFP/UNHAS in Southeast  Asia in the framework of the COVID-19 Global Humanitarian Response Plan in terms of passenger services, light cargo and MEDEVAC. With passenger planes and air ambulances (air base: Subang/Kuala Lumpur) the freedom of movement of humanitarian and development workers as well as other supporters to the Global Humanitarian Response Plan who got into “land-locked” situations where no commercial capacity is available or possible to use is enhanced by WFP/UNHAS’ air or sea transport services. 


Global co-operative movement for health

01.06.2020 - 31.12.2026

Many low- and middle-income countries strive to extend access to essential health services to the entire population. The private co-operative movement has potential to complement government efforts by providing efficient low-cost services for rural populations and informal sector workers. Following the principle of subsidiarity, SDC help the movements’ efforts establish a global platform for capacity strengthening of co-operatives.

Objet 13 – 24 de 134